RhoVac strengthens management by appointing Anders Månsson as Chief Business Officer (CBO) and deputy CEO
RhoVac AB ("RhoVac") announces today, 8 March 2019, that the company recruits Anders Månsson as Chief Business Officer (CBO) and deputy CEO to lead the ongoing activities in business development.The company has recruited Anders Månsson as Chief Business Officer (CBO) and deputy CEO to the management team, with responsibility for business development and communication. RhoVac strengthens the management team to ensure that the company has the right expertise and experience for the ongoing business development that is in parallel to further development of RhoVac's drug candidate RV001-